DocMorris AG

DOCM.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCM.SW stands at 210.22M. In comparison, BMY.SW has a market cap of 73.96B. Regarding current trading prices, DOCM.SW is priced at $17.79, while BMY.SW trades at $44.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCM.SW currently has a P/E ratio of -2.16, whereas BMY.SW's P/E ratio is 16.13. In terms of profitability, DOCM.SW's ROE is -0.26%, compared to BMY.SW's ROE of -0.23%. Regarding short-term risk, DOCM.SW is more volatile compared to BMY.SW. This indicates potentially higher risk in terms of short-term price fluctuations for DOCM.SW.

DOCM.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCM.SW stands at 210.22M. In comparison, BIIB.SW has a market cap of 30.04B. Regarding current trading prices, DOCM.SW is priced at $17.79, while BIIB.SW trades at $232.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCM.SW currently has a P/E ratio of -2.16, whereas BIIB.SW's P/E ratio is 24.54. In terms of profitability, DOCM.SW's ROE is -0.26%, compared to BIIB.SW's ROE of +0.08%. Regarding short-term risk, DOCM.SW is more volatile compared to BIIB.SW. This indicates potentially higher risk in terms of short-term price fluctuations for DOCM.SW.

DOCM.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DOCM.SW stands at 210.22M. In comparison, ROSE.SW has a market cap of 404.49M. Regarding current trading prices, DOCM.SW is priced at $17.79, while ROSE.SW trades at $35.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DOCM.SW currently has a P/E ratio of -2.16, whereas ROSE.SW's P/E ratio is -2.28. In terms of profitability, DOCM.SW's ROE is -0.26%, compared to ROSE.SW's ROE of -0.26%. Regarding short-term risk, DOCM.SW is more volatile compared to ROSE.SW. This indicates potentially higher risk in terms of short-term price fluctuations for DOCM.SW.